Scott Nelson
About Scott Nelson
Scott Nelson is a Senior Oncology Institutional Business Manager at Bristol Myers Squibb in the United States, with extensive experience in various therapeutic categories and district management.
Company
Scott Nelson currently works at Bristol Myers Squibb as a Senior Oncology Institutional Business Manager. Bristol Myers Squibb is a global biopharmaceutical company known for its focus on discovering, developing, and delivering innovative medicines for patients with serious diseases.
Title
Scott Nelson holds the title of Senior Oncology Institutional Business Manager at Bristol Myers Squibb. His role involves managing business operations and strategies within the oncology institutional segment of the company.
Professional Background
Scott Nelson has a diverse professional background in the pharmaceutical industry. Before his current role, he worked at Bristol Myers Squibb as a Senior Oncology District Business Manager from 2017 to 2021 in the Greater Portland, OR Area. He also served as Regional Business Director at Pernix Therapeutics from 2015 to 2017 and as District Manager at District Sales Manager from 2010 to 2015 in Oregon. His early career includes roles as a Professional Sales Rep and Special Markets Sales at pharmaceutical Sales Specialist and Novartis, respectively.
Education and Expertise
Scott Nelson studied at Oregon State University and earned a Bachelor's degree in Business/Corporate Communications from 2001 to 2005. He possesses over 10 years of experience in various therapeutic categories, including Specialty Pharmacy, Hospital, IDN, and Teaching Institutions. Additionally, Scott has over 8 years of experience in district management, focusing on coaching individuals to succeed and develop into advanced roles.
Medical Field Expertise
Scott Nelson has expertise in multiple medical fields, including Oncology, Neurology, Pain Management, Rheumatology, Cardiovascular Disease, Gastroenterology, and Sleep Disorders. His extensive knowledge in these areas supports his role in managing and strategizing oncology institutional business.